Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $11.48 million. The enterprise value is -$11.37 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 5.49 million shares outstanding. The number of shares has increased by 52.31% in one year.
| Current Share Class | 5.49M |
| Shares Outstanding | 5.49M |
| Shares Change (YoY) | +52.31% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 11.61% |
| Owned by Institutions (%) | 26.72% |
| Float | 4.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.66 |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.01
| Current Ratio | 7.01 |
| Quick Ratio | 6.80 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.65% and return on invested capital (ROIC) is -46.03%.
| Return on Equity (ROE) | -66.65% |
| Return on Assets (ROA) | -38.39% |
| Return on Invested Capital (ROIC) | -46.03% |
| Return on Capital Employed (ROCE) | -69.45% |
| Revenue Per Employee | $214,654 |
| Profits Per Employee | -$1.85M |
| Employee Count | 7 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.57% in the last 52 weeks. The beta is 1.57, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -65.57% |
| 50-Day Moving Average | 3.03 |
| 200-Day Moving Average | 3.40 |
| Relative Strength Index (RSI) | 32.03 |
| Average Volume (20 Days) | 17,251 |
Short Selling Information
The latest short interest is 55,649, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 55,649 |
| Short Previous Month | 43,458 |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 2.18 |
Income Statement
In the last 12 months, APRE had revenue of $1.50 million and -$12.96 million in losses. Loss per share was -$2.35.
| Revenue | 1.50M |
| Gross Profit | -7.86M |
| Operating Income | -14.32M |
| Pretax Income | -12.72M |
| Net Income | -12.96M |
| EBITDA | -14.30M |
| EBIT | -14.32M |
| Loss Per Share | -$2.35 |
Full Income StatementBalance Sheet
The company has $22.85 million in cash and n/a in debt, giving a net cash position of $22.85 million or $4.16 per share.
| Cash & Cash Equivalents | 22.85M |
| Total Debt | n/a |
| Net Cash | 22.85M |
| Net Cash Per Share | $4.16 |
| Equity (Book Value) | 20.62M |
| Book Value Per Share | 3.52 |
| Working Capital | 20.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.56 million and capital expenditures -$15,478, giving a free cash flow of -$13.57 million.
| Operating Cash Flow | -13.56M |
| Capital Expenditures | -15,478 |
| Free Cash Flow | -13.57M |
| FCF Per Share | -$2.47 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -953.00% |
| Pretax Margin | -862.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.31% |
| Shareholder Yield | n/a |
| Earnings Yield | -112.90% |
| FCF Yield | -118.24% |
Analyst Forecast
The average price target for APRE is $15.50, which is 641.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.50 |
| Price Target Difference | 641.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 95.31% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 0.05:1.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05:1 |
Scores
APRE has an Altman Z-Score of -15.67 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.67 |
| Piotroski F-Score | 3 |